Safety and Tolerability of Single and Multiple Doses of VAK694 in Healthy and Atopic Subjects

Clinical trial NCT00620230 · COMPLETED

Trial details

NCT number: NCT00620230
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Allergic Rhinitis

Start date: 2007-10-01
Primary completion: 2008-04-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.